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artery (SFA)? Nobody really knows, although many of us claim
otherwise. We can avail ourselves of open bypass or endovascular
revascularisation. The open surgical options include bypass with
autologous vein or prosthesis, while the endovascular toolkit in-
cludes angioplasty with a conventional or drug eluting balloon (DEB),
atherectomy with or without a DEB, or stenting with plenty of op-
tions to choose from: a drug eluting stent, covered stent, spiral stent,
or spot stenting. I would also wager that a lot of energy in R&D
departments is being put towards new innovations for more durable
options. Randomised controlled trials (RCTs) comparing endovas-
cular with open surgery, or endovascular devices with each other, are
scarce, and any new RCT reports are sure to receive a warm
welcome. In the current issue of this journal, we can read a paper by
Meecham and colleagues,1 who have analysed the femoropopliteal
revascularisations in the BASIL trial with almost ﬁve years follow up.
In the trial, 128 patients underwent primary bypass, while 183 pa-
tients underwent primary endovascular revascularisation for
atherosclerotic femoropopliteal disease that was causing chronic
limb threatening ischaemia without infrapopliteal revascularisation.
The authors found that while the 30 day mortality after bypass and
endovascular treatment was the same for both treatment modal-
ities, the morbidity, with the wound infection rate in particular, was
higher among bypass patients, whereas the endovascularly treated
(EVT) patients required more surgical interventions during the ﬁrst
30 days. In the long run (mean follow up 46 and 44 months after
bypass and EVT, respectively), the amputation free survival, limb
salvage rate, and wound healing rate were the same in the two
groups. However, re-interventions were needed more often after
EVT: 34% of the patients required a re-intervention, compared with
25% after bypass surgery. One in four EVT patients (47/183) even-
tually underwent bypass.
The battle between open bypass and endovascular revascular-
isation in infrainguinal PAOD has been ongoing for as long as I have
been a vascular surgeon. Over the years, I have seen aggressive
presentations by endovascular enthusiasts who have gone so far as
to show images of the funerals of open surgery patients, complete
with weeping widows dressed in black. At the same time, opinions
for the superiority of bypass surgery remain strong among many
vascular surgeons. Of all the anatomical regions, the femo-
ropopliteal is where the question regarding the best revascular-
isation technique is the most justiﬁed: both treatment methods are
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In our hospital, we perform almost 1000 procedures to revas-
cularise SFAs each year. According to the population projections, the
number of elderly patients will keep increasing for another 30 years
before the curve turns downwards. As the study by Meecham and
colleagues1 shows, this is not just a matter of the immediate
workload caused by the primary procedure, but the treatment
strategy will also have a signiﬁcant impact on future workload.
According to the incidences reported in this paper, if we treated all
our patients by endovascular means annually, we would be per-
forming 400 redo operations on the same patients during the next
ﬁve years; in comparison, the re-operation rate for open surgical
bypass would be 190.
The oldest functioning femoropopliteal bypass I have come
across during my career as a vascular surgeon was performed in
1966. The lady had also undergone aortobifemoral reconstruction
with a Dacron graft for Leriche syndrome, and now there was a
pseudoaneurysm in the groin anastomosis of the Dacron graft. This
pseudoaneurysm was repaired, and the proximal anastomosis of
the 40 year old vein bypass was transposed. During its 40 year
existence, the vein had become an artery, the wall was thick, and
the endothelium had calciﬁed plaques, but the bypass was alive
and kicking and went on to fulﬁl its purpose after the groin
reconstruction. Although the threshold to perform bypass surgery
has become higher (maybe even too high) because the endovas-
cular procedure is more achievable and requires fewer immediate
resources, such as hospital beds, operating room capacity, and
workload, open surgery remains a means to achieve an extremely
durable revascularisation.
In the BASIL substudy by Meecham et al., the fascinating question
regarding the best revascularisation method for the treatment of
occlusive SFA lesions remains unanswered, but the paper does yield
valuable information on the long-term outcome and additional re-
sources needed to maintain the revascularisation. I am not ready to
dress in black and bury open femoropopliteal region bypasses quite
yet in patients who have decent a great saphenous vein and over two
years of life expectancy. On the contrary, I expect to see a new in-
crease in this excellent procedure in these patients, as we will be
under increasing pressure to achieve durable and more cost effective
solutions in the future. However, I certainly hope that some of the
R&D departments are able to surprise me positively with an excellent
durable endovascular solution!REFERENCE
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